Feeding for Accesible, Affordable and Healthy Childhood (ALINFA)

The main objective of this study was to evaluate the effectiveness of implementing a healthy eating vs traditional recommendations on the Medkid index of children in primary school. To do so, different companies involved in ALINFA project developed with the assessment of UNAV, CNTA and UPNA, a healthy bi-weekly menu.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Navarra
      • Pamplona, Navarra, Spain, 31008
        • Center for Nutrition Research. University of Navarra

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 12 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adequate cultural level and comprehension of the clinical study from the legal tutors.
  • To agree in taking part of the study.

Exclusion Criteria:

  • Children presenting clinically relevant gastrointestinal malfunctions or structural anomalies, such as ulcers, chronic inflammatory diseases, etc. Even if they do not follow any pharmacological treatment at the moment of inclusion.
  • Children with uncontrolled endocrine disorders.
  • Children with any type of tumor/cancer within the last 5 years, or in current treatment.
  • Children with any alimentary allergy.
  • Children presenting any type of cognitive or psychic disorder
  • Parents or legal tutors in which their future collaboration may not be the required, seen from the researchers' point of view.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Control group
Subjects assigned to this arm will follow the habitual recommendations to develop skills for a healthy diet. No specific foods or cooking methods will be applied
control group
EXPERIMENTAL: ALINFA group
This group will receive, in addition to the usual recommendations, meals, and foods designed to increase the healthiness of the diet. Foods and meals have been designed to increase the fiber content, decrease sugars and saturated fats, and limit salt intake.
Comparing the usual recommendations with the healthy diet designed and developed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary Pattern (questionnaire)
Time Frame: Baseline
Evaluate differences in dietary pattern between groups
Baseline
Dietary pattern (questionnaire)
Time Frame: 8 week
Evaluate differences in dietary pattern between groups
8 week
Dietary pattern (questionnaire)
Time Frame: Baseline vs 8 week
Evaluated changes in dietary pattern
Baseline vs 8 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Santiago Navas Carretero, PhD, University of Navarra

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2021

Primary Completion (ACTUAL)

December 10, 2021

Study Completion (ACTUAL)

December 10, 2021

Study Registration Dates

First Submitted

December 9, 2021

First Submitted That Met QC Criteria

February 18, 2022

First Posted (ACTUAL)

February 21, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 21, 2022

Last Update Submitted That Met QC Criteria

February 18, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • ALINFA

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Children

Clinical Trials on Control

3
Subscribe